nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Paralysis—Tamoxifen—pancreatic cancer	0.0195	0.0294	CcSEcCtD
Mepivacaine—Urinary incontinence—Tamoxifen—pancreatic cancer	0.0131	0.0197	CcSEcCtD
Mepivacaine—Swelling—Tamoxifen—pancreatic cancer	0.0111	0.0168	CcSEcCtD
Mepivacaine—Swelling—Fluorouracil—pancreatic cancer	0.00753	0.0114	CcSEcCtD
Mepivacaine—Lidocaine—EGFR—pancreatic cancer	0.00737	1	CrCbGaD
Mepivacaine—Sweating—Tamoxifen—pancreatic cancer	0.00726	0.011	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00717	0.0108	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00698	0.0105	CcSEcCtD
Mepivacaine—Cardiac arrest—Irinotecan—pancreatic cancer	0.0066	0.00995	CcSEcCtD
Mepivacaine—Paralysis—Epirubicin—pancreatic cancer	0.00641	0.00968	CcSEcCtD
Mepivacaine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.00632	0.00953	CcSEcCtD
Mepivacaine—Chills—Erlotinib—pancreatic cancer	0.00604	0.00911	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.00602	0.00908	CcSEcCtD
Mepivacaine—Paralysis—Doxorubicin—pancreatic cancer	0.00593	0.00895	CcSEcCtD
Mepivacaine—Bradycardia—Sunitinib—pancreatic cancer	0.00593	0.00895	CcSEcCtD
Mepivacaine—Erythema—Tamoxifen—pancreatic cancer	0.00592	0.00893	CcSEcCtD
Mepivacaine—Erythema—Erlotinib—pancreatic cancer	0.00586	0.00884	CcSEcCtD
Mepivacaine—Sweating increased—Irinotecan—pancreatic cancer	0.00584	0.00881	CcSEcCtD
Mepivacaine—Back pain—Tamoxifen—pancreatic cancer	0.00573	0.00864	CcSEcCtD
Mepivacaine—Back pain—Erlotinib—pancreatic cancer	0.00567	0.00855	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.00557	0.0084	CcSEcCtD
Mepivacaine—Swelling—Docetaxel—pancreatic cancer	0.00544	0.0082	CcSEcCtD
Mepivacaine—Angioedema—Tamoxifen—pancreatic cancer	0.00541	0.00816	CcSEcCtD
Mepivacaine—Syncope—Erlotinib—pancreatic cancer	0.00525	0.00793	CcSEcCtD
Mepivacaine—Chills—Sunitinib—pancreatic cancer	0.00523	0.00789	CcSEcCtD
Mepivacaine—Loss of consciousness—Erlotinib—pancreatic cancer	0.00515	0.00777	CcSEcCtD
Mepivacaine—Sweating—Irinotecan—pancreatic cancer	0.00513	0.00773	CcSEcCtD
Mepivacaine—Hypertension—Tamoxifen—pancreatic cancer	0.00511	0.00771	CcSEcCtD
Mepivacaine—Erythema—Sunitinib—pancreatic cancer	0.00507	0.00765	CcSEcCtD
Mepivacaine—Anxiety—Tamoxifen—pancreatic cancer	0.00502	0.00758	CcSEcCtD
Mepivacaine—Sweating—Gemcitabine—pancreatic cancer	0.00499	0.00753	CcSEcCtD
Mepivacaine—Anxiety—Erlotinib—pancreatic cancer	0.00497	0.0075	CcSEcCtD
Mepivacaine—Back pain—Sunitinib—pancreatic cancer	0.00491	0.0074	CcSEcCtD
Mepivacaine—Bradycardia—Irinotecan—pancreatic cancer	0.00489	0.00737	CcSEcCtD
Mepivacaine—Oedema—Tamoxifen—pancreatic cancer	0.00483	0.00729	CcSEcCtD
Mepivacaine—Oedema—Erlotinib—pancreatic cancer	0.00478	0.00721	CcSEcCtD
Mepivacaine—Shock—Erlotinib—pancreatic cancer	0.0047	0.0071	CcSEcCtD
Mepivacaine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00467	0.00705	CcSEcCtD
Mepivacaine—Angioedema—Sunitinib—pancreatic cancer	0.00463	0.00699	CcSEcCtD
Mepivacaine—Atrioventricular block—Epirubicin—pancreatic cancer	0.00459	0.00693	CcSEcCtD
Mepivacaine—Convulsion—Sunitinib—pancreatic cancer	0.00439	0.00663	CcSEcCtD
Mepivacaine—Hypertension—Sunitinib—pancreatic cancer	0.00438	0.00661	CcSEcCtD
Mepivacaine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00434	0.00655	CcSEcCtD
Mepivacaine—Chills—Irinotecan—pancreatic cancer	0.00431	0.0065	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00425	0.00641	CcSEcCtD
Mepivacaine—Chills—Gemcitabine—pancreatic cancer	0.00419	0.00633	CcSEcCtD
Mepivacaine—Oedema—Sunitinib—pancreatic cancer	0.00414	0.00625	CcSEcCtD
Mepivacaine—Shock—Sunitinib—pancreatic cancer	0.00407	0.00614	CcSEcCtD
Mepivacaine—Erythema—Gemcitabine—pancreatic cancer	0.00407	0.00614	CcSEcCtD
Mepivacaine—Back pain—Irinotecan—pancreatic cancer	0.00404	0.0061	CcSEcCtD
Mepivacaine—Erythema—Fluorouracil—pancreatic cancer	0.004	0.00604	CcSEcCtD
Mepivacaine—Back pain—Gemcitabine—pancreatic cancer	0.00394	0.00594	CcSEcCtD
Mepivacaine—Urticaria—Tamoxifen—pancreatic cancer	0.00384	0.00579	CcSEcCtD
Mepivacaine—Body temperature increased—Erlotinib—pancreatic cancer	0.00378	0.0057	CcSEcCtD
Mepivacaine—Vision blurred—Fluorouracil—pancreatic cancer	0.00377	0.00569	CcSEcCtD
Mepivacaine—Syncope—Irinotecan—pancreatic cancer	0.00375	0.00565	CcSEcCtD
Mepivacaine—Paraesthesia—Sunitinib—pancreatic cancer	0.00372	0.00561	CcSEcCtD
Mepivacaine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00367	0.00554	CcSEcCtD
Mepivacaine—Hypertension—Irinotecan—pancreatic cancer	0.00361	0.00544	CcSEcCtD
Mepivacaine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00356	0.00537	CcSEcCtD
Mepivacaine—Hypertension—Gemcitabine—pancreatic cancer	0.00351	0.0053	CcSEcCtD
Mepivacaine—Asthenia—Tamoxifen—pancreatic cancer	0.00347	0.00523	CcSEcCtD
Mepivacaine—Convulsion—Fluorouracil—pancreatic cancer	0.00347	0.00523	CcSEcCtD
Mepivacaine—Asthenia—Erlotinib—pancreatic cancer	0.00343	0.00518	CcSEcCtD
Mepivacaine—Pruritus—Tamoxifen—pancreatic cancer	0.00342	0.00516	CcSEcCtD
Mepivacaine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00341	0.00514	CcSEcCtD
Mepivacaine—Oedema—Irinotecan—pancreatic cancer	0.00341	0.00514	CcSEcCtD
Mepivacaine—Pruritus—Erlotinib—pancreatic cancer	0.00338	0.0051	CcSEcCtD
Mepivacaine—Shock—Irinotecan—pancreatic cancer	0.00335	0.00506	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00334	0.00504	CcSEcCtD
Mepivacaine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00332	0.00501	CcSEcCtD
Mepivacaine—Oedema—Gemcitabine—pancreatic cancer	0.00332	0.00501	CcSEcCtD
Mepivacaine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.0033	0.00497	CcSEcCtD
Mepivacaine—Body temperature increased—Sunitinib—pancreatic cancer	0.00327	0.00494	CcSEcCtD
Mepivacaine—Oedema—Fluorouracil—pancreatic cancer	0.00327	0.00493	CcSEcCtD
Mepivacaine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00327	0.00493	CcSEcCtD
Mepivacaine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00321	0.00484	CcSEcCtD
Mepivacaine—Dizziness—Tamoxifen—pancreatic cancer	0.0032	0.00482	CcSEcCtD
Mepivacaine—Tachycardia—Fluorouracil—pancreatic cancer	0.00319	0.00481	CcSEcCtD
Mepivacaine—Hypotension—Irinotecan—pancreatic cancer	0.00319	0.00481	CcSEcCtD
Mepivacaine—Dizziness—Erlotinib—pancreatic cancer	0.00316	0.00477	CcSEcCtD
Mepivacaine—Hypotension—Gemcitabine—pancreatic cancer	0.0031	0.00468	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00309	0.00467	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00308	0.00464	CcSEcCtD
Mepivacaine—Vomiting—Tamoxifen—pancreatic cancer	0.00307	0.00464	CcSEcCtD
Mepivacaine—Paraesthesia—Irinotecan—pancreatic cancer	0.00306	0.00462	CcSEcCtD
Mepivacaine—Hypotension—Fluorouracil—pancreatic cancer	0.00305	0.0046	CcSEcCtD
Mepivacaine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00305	0.0046	CcSEcCtD
Mepivacaine—Vomiting—Erlotinib—pancreatic cancer	0.00304	0.00459	CcSEcCtD
Mepivacaine—Somnolence—Irinotecan—pancreatic cancer	0.00303	0.00457	CcSEcCtD
Mepivacaine—Headache—Tamoxifen—pancreatic cancer	0.00303	0.00457	CcSEcCtD
Mepivacaine—Headache—Erlotinib—pancreatic cancer	0.003	0.00452	CcSEcCtD
Mepivacaine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00298	0.0045	CcSEcCtD
Mepivacaine—Chills—Docetaxel—pancreatic cancer	0.00298	0.00449	CcSEcCtD
Mepivacaine—Asthenia—Sunitinib—pancreatic cancer	0.00297	0.00448	CcSEcCtD
Mepivacaine—Somnolence—Gemcitabine—pancreatic cancer	0.00295	0.00445	CcSEcCtD
Mepivacaine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00293	0.00442	CcSEcCtD
Mepivacaine—Pruritus—Sunitinib—pancreatic cancer	0.00293	0.00442	CcSEcCtD
Mepivacaine—Somnolence—Fluorouracil—pancreatic cancer	0.0029	0.00438	CcSEcCtD
Mepivacaine—Erythema—Docetaxel—pancreatic cancer	0.00289	0.00436	CcSEcCtD
Mepivacaine—Nausea—Tamoxifen—pancreatic cancer	0.00287	0.00433	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00285	0.00429	CcSEcCtD
Mepivacaine—Nausea—Erlotinib—pancreatic cancer	0.00284	0.00429	CcSEcCtD
Mepivacaine—Back pain—Docetaxel—pancreatic cancer	0.00279	0.00421	CcSEcCtD
Mepivacaine—Dizziness—Sunitinib—pancreatic cancer	0.00274	0.00413	CcSEcCtD
Mepivacaine—Body temperature increased—Irinotecan—pancreatic cancer	0.0027	0.00407	CcSEcCtD
Mepivacaine—Vomiting—Sunitinib—pancreatic cancer	0.00263	0.00397	CcSEcCtD
Mepivacaine—Body temperature increased—Gemcitabine—pancreatic cancer	0.00263	0.00396	CcSEcCtD
Mepivacaine—Urticaria—Fluorouracil—pancreatic cancer	0.00259	0.00391	CcSEcCtD
Mepivacaine—Headache—Sunitinib—pancreatic cancer	0.00259	0.00391	CcSEcCtD
Mepivacaine—Syncope—Docetaxel—pancreatic cancer	0.00259	0.00391	CcSEcCtD
Mepivacaine—Body temperature increased—Fluorouracil—pancreatic cancer	0.00258	0.00389	CcSEcCtD
Mepivacaine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00254	0.00383	CcSEcCtD
Mepivacaine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00251	0.00379	CcSEcCtD
Mepivacaine—Convulsion—Docetaxel—pancreatic cancer	0.0025	0.00378	CcSEcCtD
Mepivacaine—Hypertension—Docetaxel—pancreatic cancer	0.00249	0.00376	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—pancreatic cancer	0.00249	0.00376	CcSEcCtD
Mepivacaine—Nausea—Sunitinib—pancreatic cancer	0.00246	0.00371	CcSEcCtD
Mepivacaine—Asthenia—Irinotecan—pancreatic cancer	0.00245	0.00369	CcSEcCtD
Mepivacaine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00241	0.00363	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—pancreatic cancer	0.00239	0.00361	CcSEcCtD
Mepivacaine—Asthenia—Gemcitabine—pancreatic cancer	0.00238	0.0036	CcSEcCtD
Mepivacaine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00236	0.00356	CcSEcCtD
Mepivacaine—Oedema—Docetaxel—pancreatic cancer	0.00236	0.00356	CcSEcCtD
Mepivacaine—Pruritus—Gemcitabine—pancreatic cancer	0.00235	0.00355	CcSEcCtD
Mepivacaine—Shock—Docetaxel—pancreatic cancer	0.00232	0.0035	CcSEcCtD
Mepivacaine—Pruritus—Fluorouracil—pancreatic cancer	0.00231	0.00349	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—pancreatic cancer	0.00231	0.00348	CcSEcCtD
Mepivacaine—Tachycardia—Docetaxel—pancreatic cancer	0.0023	0.00347	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—pancreatic cancer	0.00228	0.00344	CcSEcCtD
Mepivacaine—Dizziness—Irinotecan—pancreatic cancer	0.00225	0.0034	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—pancreatic cancer	0.00221	0.00334	CcSEcCtD
Mepivacaine—Hypotension—Docetaxel—pancreatic cancer	0.0022	0.00332	CcSEcCtD
Mepivacaine—Vomiting—Irinotecan—pancreatic cancer	0.00217	0.00327	CcSEcCtD
Mepivacaine—Dizziness—Fluorouracil—pancreatic cancer	0.00216	0.00326	CcSEcCtD
Mepivacaine—Headache—Irinotecan—pancreatic cancer	0.00214	0.00322	CcSEcCtD
Mepivacaine—Paraesthesia—Docetaxel—pancreatic cancer	0.00212	0.00319	CcSEcCtD
Mepivacaine—Vomiting—Gemcitabine—pancreatic cancer	0.00211	0.00319	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—pancreatic cancer	0.00211	0.00318	CcSEcCtD
Mepivacaine—Somnolence—Docetaxel—pancreatic cancer	0.0021	0.00316	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—pancreatic cancer	0.00209	0.00315	CcSEcCtD
Mepivacaine—Headache—Gemcitabine—pancreatic cancer	0.00208	0.00314	CcSEcCtD
Mepivacaine—Vomiting—Fluorouracil—pancreatic cancer	0.00208	0.00313	CcSEcCtD
Mepivacaine—Headache—Fluorouracil—pancreatic cancer	0.00205	0.00309	CcSEcCtD
Mepivacaine—Nausea—Irinotecan—pancreatic cancer	0.00203	0.00306	CcSEcCtD
Mepivacaine—Chills—Epirubicin—pancreatic cancer	0.00201	0.00303	CcSEcCtD
Mepivacaine—Nausea—Gemcitabine—pancreatic cancer	0.00197	0.00298	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—pancreatic cancer	0.00195	0.00294	CcSEcCtD
Mepivacaine—Nausea—Fluorouracil—pancreatic cancer	0.00194	0.00293	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—pancreatic cancer	0.00193	0.00291	CcSEcCtD
Mepivacaine—Tension—Epirubicin—pancreatic cancer	0.00191	0.00288	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—pancreatic cancer	0.00189	0.00285	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—pancreatic cancer	0.00188	0.00284	CcSEcCtD
Mepivacaine—Body temperature increased—Docetaxel—pancreatic cancer	0.00186	0.00281	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—pancreatic cancer	0.00186	0.0028	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—pancreatic cancer	0.00184	0.00277	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—pancreatic cancer	0.0018	0.00272	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—pancreatic cancer	0.00179	0.0027	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—pancreatic cancer	0.00177	0.00267	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—pancreatic cancer	0.00175	0.00264	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—pancreatic cancer	0.00175	0.00264	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—pancreatic cancer	0.00174	0.00263	CcSEcCtD
Mepivacaine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00174	0.00262	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00171	0.00258	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—pancreatic cancer	0.0017	0.00256	CcSEcCtD
Mepivacaine—Asthenia—Docetaxel—pancreatic cancer	0.00169	0.00255	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—pancreatic cancer	0.00169	0.00255	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—pancreatic cancer	0.00168	0.00254	CcSEcCtD
Mepivacaine—Pruritus—Docetaxel—pancreatic cancer	0.00167	0.00252	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—pancreatic cancer	0.00166	0.0025	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—pancreatic cancer	0.00165	0.00249	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—pancreatic cancer	0.00162	0.00244	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—pancreatic cancer	0.00159	0.0024	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00159	0.0024	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00158	0.00239	CcSEcCtD
Mepivacaine—Shock—Epirubicin—pancreatic cancer	0.00156	0.00236	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—pancreatic cancer	0.00156	0.00236	CcSEcCtD
Mepivacaine—Dizziness—Docetaxel—pancreatic cancer	0.00156	0.00235	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—pancreatic cancer	0.00156	0.00235	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—pancreatic cancer	0.00155	0.00234	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00154	0.00232	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—pancreatic cancer	0.00153	0.00231	CcSEcCtD
Mepivacaine—Vomiting—Docetaxel—pancreatic cancer	0.0015	0.00226	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—pancreatic cancer	0.00149	0.00224	CcSEcCtD
Mepivacaine—Headache—Docetaxel—pancreatic cancer	0.00148	0.00223	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00147	0.00222	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—pancreatic cancer	0.00147	0.00222	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—pancreatic cancer	0.00145	0.00218	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—pancreatic cancer	0.00144	0.00217	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—pancreatic cancer	0.00143	0.00215	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00142	0.00215	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—pancreatic cancer	0.00141	0.00213	CcSEcCtD
Mepivacaine—Nausea—Docetaxel—pancreatic cancer	0.0014	0.00211	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—pancreatic cancer	0.00137	0.00207	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—pancreatic cancer	0.00132	0.00199	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—pancreatic cancer	0.00131	0.00197	CcSEcCtD
Mepivacaine—Urticaria—Epirubicin—pancreatic cancer	0.00126	0.00191	CcSEcCtD
Mepivacaine—SCN3A—L1CAM interactions—EGFR—pancreatic cancer	0.00126	0.00382	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IAPP—pancreatic cancer	0.00126	0.00382	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IAPP—pancreatic cancer	0.00126	0.00382	CbGpPWpGaD
Mepivacaine—Body temperature increased—Epirubicin—pancreatic cancer	0.00126	0.0019	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—KDR—pancreatic cancer	0.00124	0.00376	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MET—pancreatic cancer	0.00121	0.00368	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—EGFR—pancreatic cancer	0.00121	0.00367	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—EGFR—pancreatic cancer	0.00121	0.00367	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRP1—pancreatic cancer	0.00121	0.00366	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.00117	0.00356	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Epirubicin—pancreatic cancer	0.00117	0.00177	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—pancreatic cancer	0.00117	0.00176	CcSEcCtD
Mepivacaine—SCN1A—L1CAM interactions—EGFR—pancreatic cancer	0.00117	0.00354	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—EGFR—pancreatic cancer	0.00117	0.00354	CbGpPWpGaD
Mepivacaine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00116	0.00175	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—pancreatic cancer	0.00114	0.00172	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—SMAD4—pancreatic cancer	0.00113	0.00343	CbGpPWpGaD
Mepivacaine—Pruritus—Epirubicin—pancreatic cancer	0.00112	0.0017	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—HES1—pancreatic cancer	0.00111	0.00335	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00108	0.00164	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—pancreatic cancer	0.00106	0.00159	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—pancreatic cancer	0.00105	0.00159	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—pancreatic cancer	0.00104	0.00157	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—MMP2—pancreatic cancer	0.00101	0.00307	CbGpPWpGaD
Mepivacaine—Vomiting—Epirubicin—pancreatic cancer	0.00101	0.00153	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—KDR—pancreatic cancer	0.001	0.00304	CbGpPWpGaD
Mepivacaine—Headache—Epirubicin—pancreatic cancer	0.000996	0.0015	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—MET—pancreatic cancer	0.000982	0.00298	CbGpPWpGaD
Mepivacaine—Dizziness—Doxorubicin—pancreatic cancer	0.000973	0.00147	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—KDR—pancreatic cancer	0.00096	0.00291	CbGpPWpGaD
Mepivacaine—Nausea—Epirubicin—pancreatic cancer	0.000944	0.00142	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—MET—pancreatic cancer	0.00094	0.00285	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—SRC—pancreatic cancer	0.000936	0.00284	CbGpPWpGaD
Mepivacaine—Vomiting—Doxorubicin—pancreatic cancer	0.000935	0.00141	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—SLC2A2—pancreatic cancer	0.000933	0.00283	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KDR—pancreatic cancer	0.000923	0.0028	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KDR—pancreatic cancer	0.000923	0.0028	CbGpPWpGaD
Mepivacaine—Headache—Doxorubicin—pancreatic cancer	0.000922	0.00139	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—SMAD4—pancreatic cancer	0.000916	0.00278	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MET—pancreatic cancer	0.000903	0.00274	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MET—pancreatic cancer	0.000903	0.00274	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HES1—pancreatic cancer	0.000894	0.00271	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KDR—pancreatic cancer	0.00089	0.0027	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KDR—pancreatic cancer	0.00089	0.0027	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KDR—pancreatic cancer	0.000886	0.00269	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IAPP—pancreatic cancer	0.000885	0.00268	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SMAD4—pancreatic cancer	0.000876	0.00266	CbGpPWpGaD
Mepivacaine—Nausea—Doxorubicin—pancreatic cancer	0.000874	0.00132	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—MET—pancreatic cancer	0.000871	0.00264	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MET—pancreatic cancer	0.000871	0.00264	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MET—pancreatic cancer	0.000867	0.00263	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HES1—pancreatic cancer	0.000855	0.00259	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SMAD4—pancreatic cancer	0.000841	0.00255	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SMAD4—pancreatic cancer	0.000841	0.00255	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NOTCH1—pancreatic cancer	0.000834	0.00253	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HES1—pancreatic cancer	0.000821	0.00249	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HES1—pancreatic cancer	0.000821	0.00249	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—EGFR—pancreatic cancer	0.000821	0.00249	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP2—pancreatic cancer	0.00082	0.00248	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SMAD4—pancreatic cancer	0.000811	0.00246	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SMAD4—pancreatic cancer	0.000811	0.00246	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HES1—pancreatic cancer	0.000792	0.0024	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HES1—pancreatic cancer	0.000792	0.0024	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARG—pancreatic cancer	0.000788	0.00239	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP2—pancreatic cancer	0.000784	0.00238	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MMP9—pancreatic cancer	0.000762	0.00231	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000761	0.00231	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP2—pancreatic cancer	0.000753	0.00228	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP2—pancreatic cancer	0.000753	0.00228	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000729	0.00221	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP2—pancreatic cancer	0.000726	0.0022	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP2—pancreatic cancer	0.000726	0.0022	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP2—pancreatic cancer	0.000723	0.00219	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KDR—pancreatic cancer	0.000716	0.00217	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000702	0.00213	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—SRC—pancreatic cancer	0.000702	0.00213	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MET—pancreatic cancer	0.000701	0.00213	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KDR—pancreatic cancer	0.000685	0.00208	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—pancreatic cancer	0.000684	0.00207	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—NRAS—pancreatic cancer	0.000676	0.00205	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NOTCH1—pancreatic cancer	0.000675	0.00205	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MET—pancreatic cancer	0.000671	0.00203	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—pancreatic cancer	0.000658	0.002	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—pancreatic cancer	0.000658	0.002	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NOTCH1—pancreatic cancer	0.000646	0.00196	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—pancreatic cancer	0.000644	0.00195	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—pancreatic cancer	0.000644	0.00195	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARG—pancreatic cancer	0.000637	0.00193	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—pancreatic cancer	0.000635	0.00192	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—pancreatic cancer	0.000635	0.00192	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—pancreatic cancer	0.000625	0.0019	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MET—pancreatic cancer	0.000621	0.00188	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—pancreatic cancer	0.000621	0.00188	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NOTCH1—pancreatic cancer	0.00062	0.00188	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NOTCH1—pancreatic cancer	0.00062	0.00188	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000618	0.00187	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—pancreatic cancer	0.000616	0.00187	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—pancreatic cancer	0.000615	0.00187	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—pancreatic cancer	0.000612	0.00186	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARG—pancreatic cancer	0.000609	0.00185	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NOTCH1—pancreatic cancer	0.000598	0.00181	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NOTCH1—pancreatic cancer	0.000598	0.00181	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—pancreatic cancer	0.000589	0.00179	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARG—pancreatic cancer	0.000585	0.00177	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARG—pancreatic cancer	0.000585	0.00177	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—pancreatic cancer	0.000585	0.00177	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—pancreatic cancer	0.000581	0.00176	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SMAD4—pancreatic cancer	0.00057	0.00173	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—pancreatic cancer	0.000568	0.00172	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—pancreatic cancer	0.000566	0.00172	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—pancreatic cancer	0.000566	0.00172	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARG—pancreatic cancer	0.000564	0.00171	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARG—pancreatic cancer	0.000564	0.00171	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—pancreatic cancer	0.000559	0.0017	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HES1—pancreatic cancer	0.000557	0.00169	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CTNNB1—pancreatic cancer	0.000554	0.00168	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—pancreatic cancer	0.000553	0.00168	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—NRAS—pancreatic cancer	0.000546	0.00166	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—pancreatic cancer	0.000546	0.00165	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—pancreatic cancer	0.000546	0.00165	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—pancreatic cancer	0.000543	0.00165	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—pancreatic cancer	0.000543	0.00165	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—pancreatic cancer	0.000537	0.00163	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—pancreatic cancer	0.000537	0.00163	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00053	0.00161	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—pancreatic cancer	0.000529	0.0016	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRAS—pancreatic cancer	0.000523	0.00158	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—pancreatic cancer	0.000522	0.00158	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—pancreatic cancer	0.000522	0.00158	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—pancreatic cancer	0.000518	0.00157	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—pancreatic cancer	0.000518	0.00157	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—pancreatic cancer	0.000511	0.00155	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—pancreatic cancer	0.000508	0.00154	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—pancreatic cancer	0.000508	0.00154	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—pancreatic cancer	0.000503	0.00153	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—pancreatic cancer	0.000503	0.00153	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NRAS—pancreatic cancer	0.000502	0.00152	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRAS—pancreatic cancer	0.000502	0.00152	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—pancreatic cancer	0.000501	0.00152	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—pancreatic cancer	0.000498	0.00151	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—pancreatic cancer	0.000494	0.0015	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—pancreatic cancer	0.00049	0.00149	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—pancreatic cancer	0.00049	0.00149	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—pancreatic cancer	0.000488	0.00148	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRAS—pancreatic cancer	0.000484	0.00147	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRAS—pancreatic cancer	0.000484	0.00147	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—pancreatic cancer	0.000483	0.00147	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NRAS—pancreatic cancer	0.000482	0.00146	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—pancreatic cancer	0.000476	0.00144	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—pancreatic cancer	0.00047	0.00143	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—pancreatic cancer	0.000457	0.00139	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—pancreatic cancer	0.000457	0.00139	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—pancreatic cancer	0.00045	0.00136	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CTNNB1—pancreatic cancer	0.000448	0.00136	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—pancreatic cancer	0.000448	0.00136	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—pancreatic cancer	0.000446	0.00135	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—pancreatic cancer	0.000441	0.00134	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—pancreatic cancer	0.000441	0.00134	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—pancreatic cancer	0.00044	0.00133	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—pancreatic cancer	0.000439	0.00133	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—pancreatic cancer	0.000437	0.00132	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—pancreatic cancer	0.000432	0.00131	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—pancreatic cancer	0.000432	0.00131	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNB1—pancreatic cancer	0.000429	0.0013	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NOTCH1—pancreatic cancer	0.00042	0.00127	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—pancreatic cancer	0.00042	0.00127	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—pancreatic cancer	0.000418	0.00127	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—pancreatic cancer	0.000417	0.00126	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—pancreatic cancer	0.000417	0.00126	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—pancreatic cancer	0.000415	0.00126	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CTNNB1—pancreatic cancer	0.000412	0.00125	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNB1—pancreatic cancer	0.000412	0.00125	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—pancreatic cancer	0.000405	0.00123	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—pancreatic cancer	0.000404	0.00122	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—pancreatic cancer	0.000404	0.00122	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—pancreatic cancer	0.0004	0.00121	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNB1—pancreatic cancer	0.000397	0.0012	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CTNNB1—pancreatic cancer	0.000397	0.0012	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARG—pancreatic cancer	0.000397	0.0012	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—pancreatic cancer	0.000395	0.0012	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—pancreatic cancer	0.000391	0.00118	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRAS—pancreatic cancer	0.00039	0.00118	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—pancreatic cancer	0.000389	0.00118	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—pancreatic cancer	0.000389	0.00118	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—pancreatic cancer	0.000388	0.00118	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—pancreatic cancer	0.000384	0.00116	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—pancreatic cancer	0.000382	0.00116	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—pancreatic cancer	0.000378	0.00114	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—pancreatic cancer	0.000374	0.00113	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRAS—pancreatic cancer	0.000373	0.00113	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—pancreatic cancer	0.000372	0.00113	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—pancreatic cancer	0.000372	0.00113	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—pancreatic cancer	0.000367	0.00111	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—pancreatic cancer	0.000367	0.00111	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—pancreatic cancer	0.000364	0.0011	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—pancreatic cancer	0.000363	0.0011	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—pancreatic cancer	0.000363	0.0011	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—pancreatic cancer	0.000362	0.0011	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—pancreatic cancer	0.000359	0.00109	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—pancreatic cancer	0.000359	0.00109	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—pancreatic cancer	0.000359	0.00109	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—pancreatic cancer	0.000359	0.00109	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRAS—pancreatic cancer	0.000358	0.00109	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRAS—pancreatic cancer	0.000358	0.00109	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—pancreatic cancer	0.000355	0.00108	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—pancreatic cancer	0.000354	0.00107	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—pancreatic cancer	0.000354	0.00107	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—pancreatic cancer	0.000354	0.00107	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—pancreatic cancer	0.000353	0.00107	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—pancreatic cancer	0.00035	0.00106	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—pancreatic cancer	0.00035	0.00106	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—pancreatic cancer	0.000347	0.00105	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—pancreatic cancer	0.000346	0.00105	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—pancreatic cancer	0.000346	0.00105	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRAS—pancreatic cancer	0.000345	0.00105	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRAS—pancreatic cancer	0.000345	0.00105	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—pancreatic cancer	0.000345	0.00104	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRAS—pancreatic cancer	0.00034	0.00103	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—pancreatic cancer	0.00034	0.00103	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—pancreatic cancer	0.000338	0.00103	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—pancreatic cancer	0.000336	0.00102	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—pancreatic cancer	0.000333	0.00101	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—pancreatic cancer	0.000333	0.00101	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—pancreatic cancer	0.000326	0.00099	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—pancreatic cancer	0.000326	0.00099	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—pancreatic cancer	0.000324	0.000981	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—pancreatic cancer	0.000321	0.000973	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—pancreatic cancer	0.000321	0.000973	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—pancreatic cancer	0.000321	0.000973	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—pancreatic cancer	0.000315	0.000954	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—pancreatic cancer	0.000315	0.000954	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—pancreatic cancer	0.000311	0.000944	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—pancreatic cancer	0.000311	0.000942	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—pancreatic cancer	0.000311	0.000942	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—pancreatic cancer	0.00031	0.00094	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—pancreatic cancer	0.000308	0.000935	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—pancreatic cancer	0.000308	0.000935	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—pancreatic cancer	0.0003	0.000909	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—pancreatic cancer	0.0003	0.000909	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—pancreatic cancer	0.000297	0.000901	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—pancreatic cancer	0.000297	0.000901	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—pancreatic cancer	0.000293	0.000888	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—pancreatic cancer	0.000285	0.000865	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNB1—pancreatic cancer	0.000279	0.000847	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—pancreatic cancer	0.000274	0.00083	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—pancreatic cancer	0.000273	0.000827	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—pancreatic cancer	0.000262	0.000795	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—pancreatic cancer	0.000262	0.000795	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—pancreatic cancer	0.000253	0.000766	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—pancreatic cancer	0.000253	0.000766	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—pancreatic cancer	0.000252	0.000765	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—pancreatic cancer	0.000252	0.000764	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—pancreatic cancer	0.000249	0.000755	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—pancreatic cancer	0.000246	0.000745	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—pancreatic cancer	0.000243	0.000738	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRAS—pancreatic cancer	0.000243	0.000736	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—pancreatic cancer	0.000241	0.00073	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—pancreatic cancer	0.000231	0.000702	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—pancreatic cancer	0.000231	0.000702	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—pancreatic cancer	0.000226	0.000684	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—pancreatic cancer	0.000223	0.000677	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—pancreatic cancer	0.000223	0.000677	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—pancreatic cancer	0.000221	0.000671	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—pancreatic cancer	0.000211	0.000639	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—pancreatic cancer	0.000209	0.000634	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—pancreatic cancer	0.000178	0.000539	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—pancreatic cancer	0.000157	0.000476	CbGpPWpGaD
